Mechanistic insights into immune checkpoint inhibitor-related hypophysitis: a form of paraneoplastic syndrome

被引:0
|
作者
Keitaro Kanie
Genzo Iguchi
Hironori Bando
Shin Urai
Hiroki Shichi
Yasunori Fujita
Ryusaku Matsumoto
Kentaro Suda
Masaaki Yamamoto
Hidenori Fukuoka
Wataru Ogawa
Yutaka Takahashi
机构
[1] Kobe University Graduate School of Medicine,Division of Diabetes and Endocrinology, Department of Internal Medicine
[2] Kobe University Hospital,Division of Diabetes and Endocrinology
[3] Kobe University,Medical Center for Student Health
[4] Nara Medical University,Department of Diabetes and Endocrinology
[5] Nara,undefined
来源
关键词
Autoimmunity; Immune checkpoint inhibitor; Hypopituitarism; Hypophysitis; Paraneoplastic syndrome;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3669 / 3677
页数:8
相关论文
共 50 条
  • [41] Diaphragm involvement in immune checkpoint inhibitor-related myositis
    Sekiguchi, Kenji
    Hashimoto, Rei
    Noda, Yoshikatsu
    Tachibana, Hisatsugu
    Otsuka, Yoshihisa
    Chihara, Norio
    Shiraishi, Yusuke
    Inoue, Takaaki
    Ueda, Takehiro
    MUSCLE & NERVE, 2019, 60 (04) : E23 - E25
  • [43] A novel treatment for immune checkpoint inhibitor-related myocarditis
    Niimura, T.
    Uchida, K.
    Unten, H.
    Uno, M.
    Kanamori, M.
    Hamano, H.
    Goda, M.
    Yagi, K.
    Aizawa, F.
    Izawa-Ishizawa, Y.
    Zamami, Y.
    Ishizawa, K.
    ANNALS OF ONCOLOGY, 2023, 34 : S1634 - S1634
  • [44] Checkpoint Inhibitor-Related Immune Hepatitis and Subsequent Cirrhosis
    Chaudhary, Dhishna
    Azhar, Mishah
    Okpokpo, Enoemem M.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S1428 - S1428
  • [45] Factors Associated With Immune Checkpoint Inhibitor-Related Myocarditis
    Zamami, Yoshito
    Niimura, Takahiro
    Okada, Naoto
    Koyama, Toshihiro
    Fukushima, Keijo
    Izawa-Ishizawa, Yuki
    Ishizawa, Keisuke
    JAMA ONCOLOGY, 2019, 5 (11) : 1635 - 1637
  • [46] Immune checkpoint inhibitor-related cutaneous adverse events
    He, Chunxia
    Qu, Tao
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 (05) : E149 - E153
  • [47] Immune checkpoint inhibitor-related dermatologic adverse events
    Geisler, Amaris N.
    Phillips, Gregory S.
    Barrios, Dulce M.
    Wu, Jennifer
    Leung, Donald Y. M.
    Moy, Andrea P.
    Kern, Jeffrey A.
    Lacouture, Mario E.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (05) : 1255 - 1268
  • [48] Checkpoint Inhibitor-Related Capillary Leak Syndrome (CLS)
    Raja, Ahmad
    Kumar, Amrat
    Abdullah, Muhammad
    Daniyal, Muhammad
    Polani, Anamm
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [49] Immune checkpoint inhibitor-related myositis: from pathophysiology to treatment
    Sundarrajan, C.
    Bhai, S.
    Dimachkie, M. M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (02) : 379 - 385
  • [50] Efficacy of dupilumab in patients with immune checkpoint inhibitor-related pruritus
    Shatokhina, E.
    Kruglova, L.
    Polonskaia, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E101 - E102